During the past decade, Alberta Diabetes Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alberta Diabetes Institute" #1 collaborator was "Women and Children's Health Research Institute, Canada" with 2 trials as a collaborator, "Albert Einstein College of Medicine" with 1 trials as a collaborator, "BCDiabetes.Ca" with 1 trials as a collaborator, "DexCom, Inc." with 1 trials as a collaborator and "Emory University" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Alberta Diabetes Institute" are "Type 1 Diabetes" (4 trials), "Gastroparesis" (3 trials), "Diabetes Mellitus" (2 trials), "Coronary Artery Disease" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "Alberta Diabetes Institute" in a lesser frequency.

Most popular intervention types in "Alberta Diabetes Institute" are "Drug" (5 trials), "Behavioral" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Relamorelin" (2 trials), "Aerobic Exercise" (1 trials), "Afternoon resistance exercise" (1 trials) and "Allopurinol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alberta Diabetes Institute" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Alberta Diabetes Institute". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Alberta Diabetes Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Alberta Diabetes Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".